COMPASS Pathways plc Cash Flow Statement
CMPS / Health Care|6 years of annual SEC 10-K data (FY2019-FY2024)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 6 fiscal years. All figures from audited SEC 10-K filings.
COMPASS Pathways plc used $119M in operating cash flow and negative free cash flow of $119M in FY2024.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.93 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Net Income | -$155.1M | -$118.5M | -$91.5M | -$71.7M | -$60.3M | -$19.6M |
| Depreciation & Amortization | $233.0K | $242.0K | $330.0K | $175.0K | $112.0K | $63.0K |
| Operating Cash Flow | -$119.2M | -$97.4M | -$105.5M | -$67.7M | -$41.4M | -$17.8M |
| Capital Expenditures | $0 | $66.0K | $596.0K | $334.0K | $131.0K | $165.0K |
| Free Cash Flow | -$119.2M | -$97.4M | -$106.0M | -$68.1M | -$41.5M | -$18.0M |